Categories : Oncology
Product Packaging : 30 in HDPE
Product Composition : 250mg
Send MessageLapatinib tablets are targeted oncology medicines used primarily in the treatment of HER2-positive breast cancer. As a dual tyrosine kinase inhibitor, the formulation blocks both HER2 and EGFR pathways, helping to slow tumor growth and progression in patients requiring advanced targeted therapy.
In international pharmaceutical markets, Lapatinib tablets exporter India and breast cancer medicine supplier India are commonly searched by oncology distributors and importers. Genliva Wellness LLP, Himatnagar, operates as a pharma exporter India oncology medicines partner, supplying targeted therapy formulations to global pharmaceutical companies, healthcare institutions, and cancer treatment providers.
Lapatinib tablets are a targeted anticancer therapy formulated as a dual tyrosine kinase inhibitor acting on HER2 and EGFR pathways. The formulation is designed to block tumor growth signals and support effective treatment in specific breast cancer cases.
This medication is primarily used in the treatment of HER2-positive breast cancer, particularly in advanced or metastatic stages. It is used under specialist supervision as part of combination therapy.
The formulation provides targeted action with improved treatment precision and patient convenience. It supports better management of advanced cancer conditions.
